Guo Ying, Qiao Li-Na
College of Clinical Medicine, Sichuan University, Chengdu 610041, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2021 May;23(5):466-470. doi: 10.7499/j.issn.1008-8830.2011125.
To analyze the clinical data of children with invasive pneumococcal disease (IPD) or noninvasive pneumococcal disease (NIPD), and to provide a reference for clinical diagnosis and treatment.
A retrospective analysis was performed on the medical data and the drug susceptibility test results of isolated strains of 518 children who were hospitalized due to (SP) infection from January 2013 to December 2017. According to the location of the isolated strains, the children were divided into an IPD group with 35 children and an NIPD group with 483 children.
The children with IPD had a median age of 2.2 years, and the children aged ≤5 years accounted for 80.0%. For the children with IPD, the main type of infection was meningitis which was observed in 19 children (54.3%), and the most common underlying disease was hematological malignancy in 8 children (22.9%); 14 children (40.0%) were admitted to the pediatric intensive care unit (PICU), 18 children (51.4%) experienced complications, and 8 children (22.9%) died. For the children with NIPD, the median age was 1.2 years; the main type of infection was pneumonia in 429 children (88.8%), and the most common underlying disease was congenital heart disease in 60 children (12.4%); 60 children (12.4%) were admitted to the PICU, 102 children (21.1%) experienced complications, and 11 children (2.3%) died. The IPD group had significantly higher incidence rate of complications, PICU admission rate, and mortality rate than the NIPD group ( < 0.01). The invasive SP strains had a significantly lower susceptibility rate to penicillin than noninvasive SP strains (68.6% vs 94.2%, < 0.01).
SP infection is common in children under 5 years of age, and the children with underlying diseases including hematological malignancy are at high risk for IPD. Although the complication rate, PICU admission rate, and mortality rate of NIPD children are lower than those of IPD children, they still cannot be ignored. Penicillin may be used as an empirical treatment for children with NIPD, but not for those with IPD.
分析侵袭性肺炎球菌病(IPD)和非侵袭性肺炎球菌病(NIPD)患儿的临床资料,为临床诊断和治疗提供参考。
对2013年1月至2017年12月因肺炎链球菌(SP)感染住院的518例患儿的病历资料及分离菌株的药敏试验结果进行回顾性分析。根据分离菌株的部位,将患儿分为IPD组35例和NIPD组483例。
IPD组患儿的中位年龄为2.2岁,≤5岁的患儿占80.0%。IPD组患儿主要感染类型为脑膜炎,共19例(54.3%),最常见的基础疾病是血液系统恶性肿瘤,共8例(22.9%);14例(40.0%)入住儿科重症监护病房(PICU),18例(51.4%)出现并发症,8例(22.9%)死亡。NIPD组患儿的中位年龄为1.2岁;主要感染类型为肺炎,共429例(88.8%),最常见的基础疾病是先天性心脏病,共60例(12.4%);60例(12.4%)入住PICU,102例(21.1%)出现并发症,11例(2.3%)死亡。IPD组的并发症发生率、PICU入住率和死亡率均显著高于NIPD组(<0.01)。侵袭性SP菌株对青霉素的敏感率显著低于非侵袭性SP菌株(68.6%对94.2%,<0.01)。
SP感染在5岁以下儿童中常见,包括血液系统恶性肿瘤等基础疾病的患儿发生IPD的风险高。虽然NIPD患儿的并发症发生率、PICU入住率和死亡率低于IPD患儿,但仍不容忽视。青霉素可作为NIPD患儿的经验性治疗药物,但不适用于IPD患儿。